Results 201 to 210 of about 423,816 (314)

Current treatments for non-small cell lung carcinoma

, 2021
Antti Kaatiala
openalex   +1 more source

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material [PDF]

, 2013
Naiara G. Bediaga, Michael P.A. Davies, Amelia Acha‐Sagredo, R. Katherine Hyde, Olaide Y. Raji, Richard Page, Martin Walshaw, John R. Gosney, Ana Alfirevic, John K. Field, Triantafillos Liloglou   +10 more
openalex   +1 more source

A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity

Advanced Science, EarlyView.
In Yoo and Mainkar et al., we present a minimally invasive, CM‐selective modRNA delivery system encapsulated in lipid nanoparticles for intravenous (IV) administration. This platform enables selective cardiac translation of therapeutic modRNA but suppresses expression in off‐target tissues, including tumors.
Jimeen Yoo, Gayatri Mainkar, Matteo Ghiringhelli, Bernardo Gindri Dos Santos, Magdalena M. Żak, Keerat Kaur, Ann Anu Kurian, Matthew Adjmi, Segev Sharon, Eftychia Markopoulou, Lucia Žigová, Daniela Hirsch, Sydney Pessin, Rachel Hanan, Juan Luis Escano Abreu, Niki Brisnovali, Nicole Dubois, Leigh Goedeke, Mengcheng Shen, Lior Zangi   +19 more
wiley   +1 more source

Evaluation of TTF-1, Napsin A, p40, and p63 in the Subtyping of Non-Small Cell Lung Carcinoma: A Cross-Sectional Study from India. [PDF]

Iran J Pathol
Patel S, Anandarama Adiga DS.
europepmc   +1 more source

P1.09-07 PD-L1 Protein Expression is a Predictor of Benefit from Adjuvant Chemotherapy in Resected Non-Small Cell Lung Carcinoma [PDF]

, 2018
Naoki Yanagawa, Satoshi Shiono, Makoto Endo, Сузуки, Kazuki Hayasaka, Akimi SAITO, S Ogata   +6 more
openalex   +1 more source

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites

Advanced Science, EarlyView.
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang, Qian Shen, Yao Lin, Jing Zhu, Xiaolan Zhu, Rui Huang, Yijia Wu, Feiyang Shen, Qian Li, Guopei Zheng, Zhe Zhang, Qian Chu, Junhao Hu, Jianfeng Shen   +13 more
wiley   +1 more source

Performance and considerations in the use of diagnostic mutation panels for clonality testing in non-small-cell lung carcinoma. [PDF]

ESMO Open
Janssen J, Andrade Barbosa B, Machado JC, Hofman P, Kim Y, Ylstra B, Radonic T.   +6 more
europepmc   +1 more source

Advanced Lung Non-Small Cell Squamous Carcinoma [PDF]

, 2020
openaire   +1 more source

Characterizing Stage‐Specific Cellular Dynamics and Microenvironmental Remodeling in Lung Adenocarcinoma by Single‐Cell RNA Sequencing

Advanced Science, EarlyView.
This study integrated early‐stage patient specimens with publicly available datasets encompassing non‐malignant lung tissues and advanced‐stage LUAD through single‐cell sequencing, revealing a dynamically remodeled tumor microenvironment characterized by a hypoxia‐adapted malignant subset (C5), immunosuppressive LGMN+ macrophages, STAT1‐driven ...
Bomiao Qing, Xiaolan Li, Xiang He, Junyi Wang, Yi Yang, Manling Jiang, Bingbing Yan, Lei Zhang, Anying Xiong, Qin Ran, Guoping Li   +10 more
wiley   +1 more source

Peripheral blood neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index values as prognostic predictors for non-small cell lung carcinoma. [PDF]

Am J Transl Res
Liu Q, Hu Y, Li Y, Qian H, Shi D, Ji L.
europepmc   +1 more source